Amedisys Inc. (AMED)

AMED (NASDAQ:Health Services)
$13.60
pos +0.19
+1.42%
Today's Range: 13.28 - 13.86 | AMED Avg Daily Volume: 365,300
Last Update: 06/18/13 - 4:00 PM EDT
Volume: 218,075
YTD Performance: 18.60%
Open: $13.45
Previous Close: $13.41
52 Week Range: $8.81 - $15.95
Oustanding Shares: 31,464,919
Market Cap: 421,944,564
6-Month Chart
TheStreet Ratings Grade for AMED
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 5 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 3.00 3.00 3.00 3.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -4.66
Price Earnings Comparisons:
AMED Sector Avg. S&P 500
-4.66 0.00 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
19.41% 12.22% -71.41%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.20 -0.02 -0.01
Net Income 0.00 0.00 0.00
EPS 0.00 -1.56 0.00
Earnings for AMED:
EBITDA 0.09B
Revenue 1.49B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $0.10 $0.14 $0.51 $0.55
Number of Analysts 7 7 7 7
High Estimate $0.15 $0.17 $0.60 $0.65
Low Estimate $0.03 $0.12 $0.46 $0.44
Prior Year $0.27 $0.33 $1.08 $0.51
Growth Rate (Year over Year) -61.90% -58.44% -52.51% 7.24%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Investing in a Touchy Subject

By

Roger Arnold

| Mar 05, 2013 | 6:00 PM EST
Companies that provide end-of-life services have demographics on their side.
Bullish
Amedisys numbers raised at Jefferies
Sep 13, 2012 | 8:21 AM EDT
Shares of AMED now seen reaching $14, Jefferies said. Estimates also raised on improving admissions trends. Hold rating.
Bearish
Amedisys numbers lowered at Jefferies
May 09, 2012 | 8:32 AM EDT
Shares of AMED now seen reaching $15, Jefferies said. Estimates also lowered on reimbursement uncertainty. Hold rating.

A Cure for What Ails Us

By

Roger Arnold

| Apr 19, 2012 | 4:30 PM EDT
These stocks stand to benefit if Americans can accept the fact that rising health care costs aren't magically going away.
Bullish
Amedisys numbers raised at Jefferies
Mar 21, 2012 | 8:26 AM EDT
Shares of AMED now seen reaching $16.50, Jefferies said. Estimates also raised to reflect benefit of agency rationalization efforts. Ho...

The Insurance Contagion

By

Roger Arnold

| Oct 20, 2011 | 4:00 PM EDT
Financial pain caused by a flat yield curve will cascade from the insurance industry into health care.

Columnist Conversation / Market Updates

Paris to join Brazil and Turkey this summer?
By Bret Jensen
| Jun 18, 2013
| 10:33 PM EDT
Good piece by Niall Ferguson on how protests going on in Brazil & Turkey could hit next in France over the summer. ...
Baltic Dry index
By Jim Cramer
| Jun 18, 2013
| 6:31 PM EDT
Now up to 962--It flagged things on the way down. could be doing it again.
See all »

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.